Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 4, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • DNA-Tales
  • Pale and Cold Hands? Maybe Raynaud’s Phenomena

Biotech & Life Science Research Associate – Rs. 49,000 pm Pay at RCB

CSIR-NCL Jobs | Rs. 1 Lakh pm Pay | Biotech/Life Science & Microbiology Apply

Pale and Cold Hands? Maybe Raynaud’s Phenomena
  • Biotechnopedia
  • DNA-Tales

Pale and Cold Hands? Maybe Raynaud’s Phenomena

bioxone November 6, 2020November 5, 2020

Shrestha Sherry Chakraborty, Amity University Kolkata

Raynaud’s phenomenon or Raynaud’s syndrome is a condition characterized by vasospasm which is generally caused by excessive constriction of small arteries supplying blood to different body parts. This leads to a limited supply of blood and oxygen to the affected area. Low oxygen levels eventually cause necrosis of the affected tissue. 

Symptoms are mostly characterized by numbness of the affected area along with changes in the colouration of the skin. Colour can be bright red or bluish-green, due to the lack of oxygen. It may lead to burns and loss of sensation in the affected area and these symptoms are often accompanied by pain.

FORMS OF RAYNAUD’S SYNDROME

Raynaud’s syndrome can often occur on its own and this form is called the primary form of the disease. When it is accompanied by another disease, it is then known as the secondary form of Raynaud’s syndrome. In such cases, it is mostly associated with connective tissue diseases like systemic lupus erythematosus.

 Raynaud’s phenomenon is most prevalent in the female population, especially in younger females. Some anti-migraine drugs have shown to cause the secondary form of Raynaud’s syndrome. However, in older populations, obstructive pulmonary disease is a cause of Raynaud syndrome. The secondary form of Raynaud’s syndrome may also be associated with malignancy and infections like Hepatitis B and Hepatitis C. 

MECHANISM OF RAYNAUD’S SYNDROME

The three main phenomena that occur in this disease are vasoconstriction, decreased blood flow to the affected area accompanied by immune responses, and inflammation. In the primary form of the disease, increased sensitivity of alpha-2 adrenergic in the digital and cutaneous blood vessels leads to vasoconstriction in response to low temperatures. Alpha-2 adrenergic receptors are present on the smooth muscles of the arteries of the digits. However, in the secondary form of the syndrome, the pre-existing disease prevents blood vessels from responding to temperature fluctuations. The endothelial properties of the digital and cutaneous blood vessels get disrupted, leading to subsequent constriction. 

TREATMENT:

Treatment for Raynaud’s Syndrome mainly aims at the prevention of ischemia and reducing the severity of attacks. Lifestyle modifications such as refraining from cold and keeping warm as much as possible along with the reduction of emotional stress can play a very important part.

1. Calcium channel blockers are the first choice of drugs but it may lead to certain side effects like headaches and palpitations among many others. 

2. Phosphodiesterase inhibitors – This is used when the patient fails to respond to or partially responds to calcium channel blockers.

3. Topical nitrates- nitroglycerine ointment in the affected areas is used but it has side effects such as dizziness and headaches.

4. Prostaglandins- It is administered when there are symptoms of ischemia and it also prevents the accumulation of platelets.

The response of a patient to treatment is generally assessed based on the ‘Raynaud Condition Score’, which generally focuses on the severity of attacks, the quality of life before and after medications, and the overall effect of the syndrome on the person. 

Thus, these are the different ways by which Raynaud’s Syndrome can be treated and managed to lead a more manageable and peaceful life. 

Also read: Tumorigenic Transformation of Stem Cells can cause Cancers

Source:

1. Musa R, Qurie A, . Raynaud Disease (Raynaud Phenomenon, Raynaud Syndrome 2020,.

https://www.ncbi.nlm.nih.gov/books/NBK499833/?report=printable

2. Ventura I, Reid P, Jan R. Approach to Patients with Suspected Rheumatic Disease. Prim. Care. 2018 Jun;45(2):169-180. [PubMed: 29759118].

3. Picture Credit: https://www.hopkinsmedicine.org/health/conditions-and-diseases/raynauds-phenomenon

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

One thought on “Pale and Cold Hands? Maybe Raynaud’s Phenomena”

  1. Pingback: Gene therapy clinical trials for rare Angelman syndrome put on hold - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

CSIR-NCL Jobs | Rs. 1 Lakh pm Pay | Biotech/Life Science & Microbiology Apply

bioxone November 6, 2020

-Shristi Sharma, Team bioXone CSIR-NCL Jobs W/Rs. 1 Lakh pm Pay – Biotech/Life Science & Microbio Apply. NCL Pune is hiring BTech Biotech/ BSc & MSc Life Science/Microbiology candidates for project positions. Interested and eligible candidates check out all of the details below:  CSIR-NATIONAL CHEMICAL LABORATORY Dr Homi Bhabha Road, Pune – 411008 Advertisement No. […]

Related Post

  • Biotechnopedia

Using spider-silk to develop the next-gen biomaterials

bioxone September 25, 2020September 25, 2020

-Kumar Shivam, Amity University Kolkata Spiders. The word itself can cause shivers down the spine of many people. While the fear of our beloved eight-legged creature has kept many at bay in coming contact with them, some of the brilliant minds from the country of Germany had gathered together to find an ingenious method to […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Biotechnopedia
  • DNA-Tales

Prosopagnosia- A Room Full Of Strangers Everyday!

BioTech Today June 23, 2021June 22, 2021

Moumita Ghosh, Amity University Kolkata Introduction Prosopagnosia is an impairment that causes the inability to acknowledge previously known faces and to find out new faces. It is also known as “face-blindness”. It may occur as a developmental variant or after a brain lesion. Humans have acquired the flexibility of recognizing faces effortlessly, rapidly, and accurately […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Biotechnopedia
  • DNA-Tales

THE BRAIN’S REWARD SYSTEM: NEUROBIOLOGY OF DRUG ADDICTION

bioxone February 8, 2021February 8, 2021

Shinjini Bandopadhyay, Amity University Kolkata Addiction is defined as a chronic, relapsing disease of the brain. It is a biological process that alters the neurochemical pathways in the brain. Although addictions may be of varying types, the most frequently occurring and the most damaging ones include substance abuse (drugs, alcohol, tobacco). Substance abuse physically affects […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy